Minerva Biotechnologies Corporation
1 clinical trials · Sponsor
◉ Watch Minerva Biotechnologies Corporation
| Record | Firm | Date |
|---|---|---|
| Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) (NCT04020575) | Minerva Biotechnologies Corporation | 2020-01-15 |
Track Minerva Biotechnologies Corporation automatically
Every clearance here is in the API, with alerts when new ones post.